Orange Book product · Brand (NDA)
STAXYN
VARDENAFIL HYDROCHLORIDE
At a glance
Jun 17, 2010
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 17, 2010
16 yr 3 mo ago
Today
Patent 8613950 expires
Listed drug product patent expiration.
Dec 23, 2028
in 2 yr 7 mo
Pharmaceutical detail
Active ingredient
VARDENAFIL HYDROCHLORIDE
Strength
10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
TE code
Not listed
Application
NDA 200179
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2003LEVITRABrand (NDA)
NDA 021400 · BAYER HLTHCARE
- 2020VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 214031 · ALEMBIC
- 2020VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 205988 · MACLEODS PHARMS LTD
- 2019VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 204632 · MACLEODS PHARMS LTD
- 2018VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 208324 · ALEMBIC
- 2018VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 209057 · CROSSMEDIKA SA
- 2018VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 210738 · STEVENS J
- 2018VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 208960 · ZYDUS PHARMS
- 2012VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 091347 · TEVA PHARMS
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8613950 | Dec 23, 2028 | in 2 yr 7 mo | Product |

